, Volume 12, Issue 1, pp 47–60 | Cite as

Biogerontology in Russia: from past to future

  • Vladimir N. Anisimov
  • Vladimir Kh. Khavinson
  • Olga N. Mikhailova
Original Paper


The paper presents major steps of gerontology development in Russia. The issues of training in gerontology and geriatrics, institutional infrastructure within the Gerontological Society of the Russian Academy of Sciences and its activities have been considered therein. Some results of Russian researchers obtained during 2005–2010 have been summarized as well. Special attention is given to the prospects of gerontology in Russia.


Aging research Biogerontology Main results Russia 



N.M. Emanuel Institute of Biochemical Physics, RAS


Institute of Chemical Physics, RAS


Institute of Genetics and Cytology, Siberian Branch of the RAS


A.N. Belozersky Institute of Physical and Chemical Biology


Institute of Problems of Chemical Physics, RAS


The Russian Academy of Medical Sciences


The Russian Academy of Sciences


Research Institute of Experimental Medicine, RAMS


D.O. Ott Research Institute of Obstetrics and Gynecology, RAMS


Scientific-Medical Center of the Committee of Veterans of Special Risk Subdivisions in Russian Federation




St. Petersburg Institute of Bioregulation and Gerontology, North-Western Branch RAMS


  1. Abatnina JV, Bazhanova ED, Teply DL (2005) Role of vitamin E in regulation apoptosis at pathology and aging. Adv Gerontol 17:29–33Google Scholar
  2. Alimova IN, Liu B, Fan Z, Edgerton SM, Dillon T, Lind SE, Thor AD (2009) Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro. Cell Cycle 8:909–915PubMedCrossRefGoogle Scholar
  3. Alishev NV, Vashkevich AA, Drabkin BA, Koroleva TM, Kosickaya LS, Shubik VM (2007) Accelerated aging of immune system of the veterans of special risk subdivisions. Adv Gerontol 20:96–111PubMedGoogle Scholar
  4. Alishev NV, Drabkin BA, Shubik VM (2010) Stress-immunity-health (problem of precocious aging in veterans of special risk subdivisions). Adv Gerontol 23:49–55PubMedGoogle Scholar
  5. Anisimov VN (2001) Experimental research on ageing in Russia. Exp Gerontol 26:935–946CrossRefGoogle Scholar
  6. Anisimov VN (2005) Biological interactions of aging and carcinogenesis. Cancer Treat Res 124:17–50PubMedCrossRefGoogle Scholar
  7. Anisimov VN (2006a) Effect of host age on tumor growth rate in rodents. Front Biosci 11:412–422PubMedCrossRefGoogle Scholar
  8. Anisimov VN (2006b) Light pollution, reproductive function and cancer risk. Neuro Endocrinol Lett 27:35–52PubMedGoogle Scholar
  9. Anisimov VN (2006c) Premature ageing prevention: limitations and perspectives of pharmacological interventions. Curr Drugs Targets 7:1485–1503Google Scholar
  10. Anisimov VN (2007) Biology of aging and cancer. Cancer Control 14:23–31PubMedGoogle Scholar
  11. Anisimov VN (2008) Antidiabetic drugs in aging and cancer: results and perspectives. Open Aging J 2:36–48Google Scholar
  12. Anisimov VN (2009) Carcinogenesis and aging 20 years after: escaping horizon. Mech Ageing Dev 130:105–121PubMedCrossRefGoogle Scholar
  13. Anisimov VN, Khavinson VKh (2010) Peptide bioregulation of aging: results and prospects. Biogerontology 11:139–149PubMedCrossRefGoogle Scholar
  14. Anisimov VN, Khavinson VKh (2003) Small peptide-associated modulation of aging and longevity. In: Rattan SIS (ed) Modulating aging and longevity. Kluwer Academic Publishers, Dordrecht, pp 279–301Google Scholar
  15. Anisimov VN, Khavinson VKh (2005) Pineal peptides as modulators of aging. In: Rattan SIS (ed) Aging interventions and therapies. World Scientific, Singapore, pp 127–146Google Scholar
  16. Anisimov VN, Khavinson VKh, Mikhalski AI, Yashin AI (2001) Effect of synthetic thymic and pineal peptides on biomarkers of ageing, survival and spontaneous tumour incidence in female CBA mice. Mech Ageing Dev 122:41–68PubMedCrossRefGoogle Scholar
  17. Anisimov SV, Boheler KR, VKh Khavnson, Anisimov VN (2002a) Studies of the effects of Vilon and Epithalamin ongene expression in mouse heart using DNA-microarray technology. Bull Exp Biol Med 133:293–299PubMedCrossRefGoogle Scholar
  18. Anisimov VN, Khavinson VKh, Provinciali M, Alimova IN, Baturin DA, Popovich IG, Zabezhinski MA, Imyanitov EN, Mancini R, Franceschi C (2002b) Inhibitory effect of the peptide epitalon on the development of spontaneous mammary tumors in Her-2/NEU transgenic mice. Int J Cancer 101:7–10PubMedCrossRefGoogle Scholar
  19. Anisimov VN, Khavinson VKh, Popovich IG, Zabezhinski MA, Alimova IN, Rosenfeld SV, Zavarzina NYu, Semenchenko AV, Yashin AI (2003) Effect of epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice. Biogerontology. 4:193–202Google Scholar
  20. Anisimov SV, Boheler KR, Khavinson VKh, Anisimov VN (2004) Elucidation of the effect of brain cortex tetrapeptide Cortagen on gene expression in mouse heart by microarray. Neuro Endocrinol Lett 25:87–93PubMedGoogle Scholar
  21. Anisimov VN, Berstein LM, Egormin PA, Piskunova TS, Popovich IG, Zabezhinski MA, Kovalenko IG, Poroshina TE, Semenchenko AV, Provinciali M, Re F, Franceschi C (2005) Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice. Exp Gerontol 40:685–693PubMedCrossRefGoogle Scholar
  22. Anisimov VN, Popovich IG, Zabezhinski MA, Anisimov SV, Vesnushkin GM, Vinogradova IA (2006) Melatonin as antioxidant, geroprotector and anticarcinogen. Biochim Biophys Acta 1757:573–589PubMedCrossRefGoogle Scholar
  23. Anisimov VN, Popovich IG, Zabezhinski MA (2007) Methods of evaluating the effect of pharmacological drugs on aging and life span in mice. Methods Mol Biol 371:227–236PubMedCrossRefGoogle Scholar
  24. Anisimov VN, Baranov VS, Khavinson VKh, Kozlov LV, Mikhailova ON, Ryzhak GA, Kvetnoy IM, Kvetnaya TV, Malinin VV (2008a) Programme for prevention of age-related pathology and accelerated ageing, reduction of premature mortality due to biological reasons and extension of healthy period of life for the population of Russia. KOSTA, St. Petersburg, 72 ppGoogle Scholar
  25. Anisimov VN, Berstein LM, Egormin PA, Piskunova TS, Popovich IG, Zabezhinski MA, Tyndyk ML, Yurova MV, Kovalenko IG, Poroshina TE, Semenchenko AV (2008b) Metformin slows down aging and extends life span of female SHR mice. Cell Cycle 7:2769–2773PubMedCrossRefGoogle Scholar
  26. Anisimov VN, Sikora E, Pawelec G (2009) Relationships between cancer and aging: multilevel approach. Biogerontology 10:323–338PubMedCrossRefGoogle Scholar
  27. Anisimov VN, Egormin PA, Piskunova TS, Popovich IG, Tyndyk ML, Yurova MV, Zabezhinski MA, Anikin IV, Karkach AS, Romanyukha AA (2010a) Metformin extends life span of HER-2/neu transgenic mice and in combination with melatonin inhibits growth of transplantable tumors in vivo. Cell Cycle 9:188–197PubMedCrossRefGoogle Scholar
  28. Anisimov VN, Zabezhinski MA, Popovich IG, Piskunova TS, Semenchenko AV, Tyndyk ML, Yurova MV, Antoch MP, Blagosklonny MV (2010b) Rapamycin extends maximal life span in cancer-prone mice. Am J Pathol 176:2092–2097PubMedCrossRefGoogle Scholar
  29. Babizhaev MA, Yegorov YE (2010) Telomere attrition in lens epithelial cells—a target for N-acetylcarnosine therapy. Front Biosci 15:934–956CrossRefGoogle Scholar
  30. Baranov VS, Baranova EV (2007) Genetic aspects of ageing. Adv Gerontol 20(2):26–34PubMedGoogle Scholar
  31. Bashkireva AS, Khavinson VKh (2007) Occupational risk of accelerated ageing in motor transport drivers. Med Tr Prom Ekol 11:13–21PubMedGoogle Scholar
  32. Bashkireva AS, Artamonova VG, Khavinson VKh (2009) Productive aging or “healthy worker effect”? Retrospective analysis of morbidity with temporal workability loss in motor transport driver. Adv Gerontol 22:539–547PubMedGoogle Scholar
  33. Batin M, Moskalev A, Novoseltsev V, Michalski A, Tereshina E. (2009) “Science against aging”—a complex interdisciplinary program of fundamental research. PA6 047. J Nutr Health Aging 13(Suppl 1):S218Google Scholar
  34. Berstein LM (2005) Clinical usage of hypolipidemic and antidiabetic drugs in the prevention and treatment of cancer. Cancer Lett 224:203–212PubMedCrossRefGoogle Scholar
  35. Blagosklonny MV, Campisi J, Sinclair DA, Bartke A, Blasco MA, Bonner WM, Bohr VA, Brosh RM Jr, Brunet A, Depinho RA, Donehower LA, Finch CE, Finkel T, Gorospe M, Gudkov AV, Hall MN, Hekimi S, Helfand SL, Karlseder J, Kenyon C, Kroemer G, Longo V, Nussenzweig A, Osiewacz HD, Peeper DS, Rando TA, Rudolph KL, Sassone-Corsi P, Serrano M, Sharpless NE, Skulachev VP, Tilly JL, Tower J, Verdin E, Vijg J (2010) Impact papers on aging in 2009. Aging (Albany NY) 2:111–121Google Scholar
  36. Boldyrev AA, Stvolinsky SL, Fedorova TN, Suslina ZA (2010) Carnosine as a natural antioxidant and geroprotector: from molecular mechanisms to clinicl trials. Rejuvenation Res 13:156–158PubMedCrossRefGoogle Scholar
  37. Butov AA, Volkov MA, Anisimov VN, Yashin AI (2002) A model of accelerated aging induced by 5-bromodeoxyuridine. Biogerontology 3:175–182PubMedCrossRefGoogle Scholar
  38. De Luca M, Roshina NV, Geiger-Thornsberry GL, Lyman RF, Pasyukova EG, Mackay TF (2003) Dopa decarboxylase (Ddc) affects variation in Drosphila longevity. Nat Genet 34:429–433PubMedCrossRefGoogle Scholar
  39. Demyanov VF (2005) A mathematical model of the evolution and aging. Adv Gerontol 17:18–28Google Scholar
  40. Deriabina ON, Plotnikova NA, Anisimov VN (2010a) Melatonin and metformin inhibit benz(a)pyrene-induced skin carcinogenesis in mice. Vopr Onkol (in press)Google Scholar
  41. Deriabina ON, Plotnikova NA, Kharitonova TV, Kirichenko EV, Soldatov IV, Anisimov VN (2010b) Melatonin and metformin inhibit benz(a)pyrene-induced cervico-vaginal carcinogenesis in mice. Morphol Vedomosti (in press)Google Scholar
  42. Dilman VM (1971) Age-associated elevation of hypothalamic threshold to feedback control and its role in development, aging and disease. Lancet 1:1211–1219PubMedCrossRefGoogle Scholar
  43. Dilman VM, Anisimov VN (1980) Effect of treatment with phenfromin, dyphenylhydantoin or L-DOPA on life span and tumor incidence in C3H/Sn mice. Gerontology 26:241–245PubMedCrossRefGoogle Scholar
  44. Duplenko Yu K (1985) Aging. The essay of the problem development. Nauka, Leningrad, 192 ppGoogle Scholar
  45. Evans JM, Donnelly LA, Emslie-Smith AM, Alessi DR, Morris AD (2005) Metformin and reduced risk of cancer in diabetic patients. BMJ 330:1304–1305PubMedCrossRefGoogle Scholar
  46. Gladyshev GP (2005) The second law of thermodynamics and the evolution of living systems. J Human Thermodyn 1:68–81Google Scholar
  47. Gladyshev GP (2006) The principle of substance stability is applicable to all levels of organization of living matter. Int J Mol Sci 7:98–110CrossRefGoogle Scholar
  48. Glotov OS, Baranov VS (2007) Genetic polymorphism and aging. Adv Gerontol 20(2):35–54PubMedGoogle Scholar
  49. Golubev AG (2009a) The issue of feasibility of a general theory of aging. I. Generalized Gompeertz–Makeham law. Adv Gerontol 22:60–73PubMedGoogle Scholar
  50. Golubev AG (2009b) The issue of feasibility of a general theory of aging. II. The parametabolic theory of aging. Adv Gerontol 22:205–222PubMedGoogle Scholar
  51. Goncharova ND, Vengerin AA, Khavinson VKh, Lapin BA (2005) Pineal peptides restore the age-related disturbances in hormonal functions of the pineal gland and the pancreas. Exp Gerontol 40:51–57PubMedCrossRefGoogle Scholar
  52. Goncharova ND, Shmaliy AV, Bogatyrenko TN, Koltover VK (2006) Correlation between activity of antioxidant enzymes and circadian rhythms of corticseroids in Macaca mulatta monkeys of different age. Exp Gerontol 41:778–783PubMedCrossRefGoogle Scholar
  53. Goncharova ND, Shmaliy AV, Marenin VY, Smelkova SA, Lapin BA (2008) Circadian and age-related changes in stress resposiveness of the adrenal cortex and erythrocyte antioxidant enzymes in female rhesus monkey. J Med Primatol 37:229–238PubMedCrossRefGoogle Scholar
  54. Imyanitov EN (2009) Use of elderly tumor-free subjects as a “supercontrol” for cancer epidemiological studies: pros and cons. Mech Ageing Dev 130:122–127PubMedCrossRefGoogle Scholar
  55. Khavinson VKh (2002) Peptides and ageing. Neuro Endocrinol Lett 23(Suppl 3. special issue):11–144Google Scholar
  56. Khavinson VKh, Malinin VV (2005) Gerontological aspects of genome peptide regulation. Karger AG, Basel (Switzerland), 104 ppGoogle Scholar
  57. Khavinson VKh, Mikhailova ON (2007) Health and aging in Russia. In: Robinson M, Novelli W, Pearson C, Norris L (eds) Global health and global aging. AARP Foundation, Jossey-Bass, USA, pp 226–237Google Scholar
  58. Khavinson VKh, Goncharova N, Lapin B (2001) Synthetic tetrapeptide epitalon restores disturbed neuroendocrine regulation in senescent monkeys. Neuro Endocrinol Lett 22:251–254PubMedGoogle Scholar
  59. Khavinson V, Razumovsky M, Trofimova S, Grigorian R, Razumovskaya A (2002) Pineal-regulating tetrapeptide epitalon improves eye retina condition in retinitis pigmentosa. Neuro Endocrinol Lett 23:365–368PubMedGoogle Scholar
  60. Khavinson VKh, Lezhava TA, Monaselidze JR, Jokhadze TA, Dvalis NA, Bablishvili NK, Trofimova SV (2003) Peptide Epitalon activates chromatin at the old age. Neuro Endocrinol Lett 24:329–333PubMedGoogle Scholar
  61. Khavinson V, Bondarev I, Butyugov A (2004a) Epitalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bull Exp Biol Med 135:590–592CrossRefGoogle Scholar
  62. Khavinson V, Bondarev I, Butyugov A, Smirnova T (2004b) Peptide promotes overcoming of the division limit in human somatic cell. Bull Exp Biol Med 137:613–616Google Scholar
  63. Khavinson V, Shataeva L, Chernova A (2005) DNA double-helix binds regulatory peptides similarly to transcription factors. Neuro Endocrinol Lett 26:237–241PubMedGoogle Scholar
  64. Khavinson VKh, Solovyov AY, Shataeva LK (2008) Melting of DNA double strand after binding to geroprotective tetrapeptide. Bull Exp Biol Med 146:624–626PubMedCrossRefGoogle Scholar
  65. Koltover VK (2009) Bioantioxidants: the systems reliability standpoint. Toxicol Ind Health 25:295–299PubMedCrossRefGoogle Scholar
  66. Kosarev VV, Babanov SA, Gaydisn PV (2009) The problem of premature senescence in professional diseases of lungs. Adv Gerontol 22:660–661PubMedGoogle Scholar
  67. Kossoy G, Zandbank J, Tendler E, Anisimov VN, Khavinson VKh, Popovich IG, Zabezhinski MA, Zusman I, Ben-Hur H (2003) Epitalon and colon carcinogenesis in rats: proliferative activity and apoptosis in colon tumors and mucosa. Int J Mol Med 12:473–477PubMedGoogle Scholar
  68. Kozina LS, Arutjunyan AV, Khavinson VKh (2007) Antioxidant properties of geroprotective peptides of the pineal gland. Arch Gerontol Geriatr 44(Suppl 1):213–216Google Scholar
  69. Kudryavtseva TK (ed) (2007a) Gerontology and geriatrics. Bibliography of publications of Russian researchers in 1994–2006. St. PetersburgGoogle Scholar
  70. Kudryavtseva TK (ed) (2007b) Gerontology and geriatrics. Contribution of Russia to world gerontology. Bibliography of publications of Russian researchers in International Monographs and Journals, 1994–2006. St. PetersburgGoogle Scholar
  71. Liu B, Fan Z, Edgerton SM, Deng XS, Alimova IN, Lind SE, Thor AD (2009) Metformin induces unique biological and molecular responses in triple negative breast cancer cells. Cell Cycle 8:2031–2040PubMedCrossRefGoogle Scholar
  72. Magwire MM, Yamamoto A, Carbone MA, Roshina NV, Symonenko AV, Pasyukova EG, Morozova TV, Mackay TF (2010) Quantitative and molecular genetic analyses of mutations increasing Drosphila life span. PLoS Genet 6(7):e1001037PubMedCrossRefGoogle Scholar
  73. Makrushin AV (2008) Is the mankind under the threat of extinction? Adv Gerontol 21:353–355PubMedGoogle Scholar
  74. Mamaev VB, Tsarin AA (2007) Historical dynamics of age-related mortality. 2. Sexual dimorphism and calculation issues. Adv Gerontol 20:20–28PubMedGoogle Scholar
  75. Marchuk GI, Anisimov VN, Romaniukha AA, Yashin AI (2007) Gerontologia in silico: establishment of a new discipline. Mathematical models, data analysis and calculation expreiments. BINOM, Laboratory of Knowledge, Moscow, 535 ppGoogle Scholar
  76. Martin-Castillo B, Vazquez-Martin A, Oliveras-Ferraros C, Menendez JA (2010) Metformin and cancer. Doses, mechanisms and the dandelion and hermetic phenomena. Cell Cycle 9:1057–1064CrossRefGoogle Scholar
  77. Mikhailova ON, Anisimov VN, Sidorenko AV (2005) Development of gerontology in Russia: the Role of International Collaboration, Firm Kosta, St. PetersburgGoogle Scholar
  78. Mikhalski AI, Novoseltsev VN (2005) Quantitative analysis and modeling of aging, disability and mortality. Adv Gerontol 17:117–129Google Scholar
  79. Moldaver MV, Yegorov YE (2009) Sparse plating increases the heterogeneity of proliferative potential of fibroblasts. Mech Ageing Dev 130:337–342PubMedCrossRefGoogle Scholar
  80. Moskalev AA (2008) About genetic determinants of aging pathways. Adv Gerontol 21:463–469PubMedGoogle Scholar
  81. Moskalev AA (2010) Evolution conception about the aging nature. Adv Gerontol 23:9–20PubMedGoogle Scholar
  82. Moskalev AA, Plyusnina EN (2007) Drosophila melanogaster recessive lethal mutation in X-chromosome locus 6d1–7a2 in heterozygote leads to life span increasing. Adv Gerontol 20(4):36–39PubMedGoogle Scholar
  83. Moskalev AA, Shaposhnikov MV (2010) Pharmacological inhibition of phosphoinositide 3 and TOR kinases improves survival of Drosophila melanogaster. Rejuvenation Res 13:246–247PubMedCrossRefGoogle Scholar
  84. Obukhova LA, Skulachev VP, Kolosova NG (2009) Mitochondria-targeted antioxidant SkQ inhibits age-dependent involution of the thymus in normal and senescence-prone rats. Aging (Albany NY) 1:389–401Google Scholar
  85. Olovnikov AM (2007) Hypothesis: lifespan is regulated by chronomere DNA of the hypothalamus. J Alzheimers Dis 11:241–252PubMedGoogle Scholar
  86. Pauk VV, Nasibullin TR, Tuktarova IA, Zueva LP, Mustafina OE (2008) Antioxidant gene polymorphism in connection with life span. Adv Gerontol 21:593–595PubMedGoogle Scholar
  87. Pirozhkov SI, Safarova GL, Schebrov SY (2007) Population ageing in Russia and Ukraine: look into future. Adv Gerontol 20(2):14–22PubMedGoogle Scholar
  88. Piskunova TS, Yurova MN, Zabezhinski MA, Anisimov VN (2007) Poly(ADP-ribosa)polymerase—the relationship with life span and carcinogenesis. Adv Gerontol 20(2):82–90PubMedGoogle Scholar
  89. Piskunova TS, Yurova MN, Ovsjannikov AI, Semenchenko AV, Zabezhinski MA, Popovich IG, Wang Z-Q, Anisimov VN (2008) Deficiency in poly(ADP-ribose) polymerase-1 (PARP-1) accelerates aging and spontaneous carcinogenesis in mice. Current Gerontol Geriatr Res Vol 2008, Article ID 754190, 11 pp. doi: 10.1155/2008/754190
  90. Polubotko EA, Shatrova AN, Pleskach NM, Mikhelson VM, Spivak IM (2009) Cellular repair potential in families of ataxia-telangiectasia patients. Tsitologiia 51:978–985PubMedGoogle Scholar
  91. Popov IY (2008) Species senescence: facts or illusion? Adv Gerontol 21:181–194PubMedGoogle Scholar
  92. Pospelova TV, Demidenko ZH, Bukreeva EI, Pospelov VA, Gudkov AV, Blagosklonny MV (2009) Pseudo-DNA damage response in senescent cells. Cell Cycle 8:4112–4118PubMedCrossRefGoogle Scholar
  93. Rybina OY, Pasyukova EG (2010) A naturally occurring polymorphism at Drosophila melanogaster Lim3 Locus, a homolog of human LHX3/4, affects Lim3 transcription and fly lifespan. PLoS One 5(9):e12621PubMedCrossRefGoogle Scholar
  94. Safarova GL, Kosolapenko NV, Atutionov VA (2005) Regional differentiation of ageing in Russia. Adv Gerontol 16:7–13PubMedGoogle Scholar
  95. Schwartzburd PM (2008) Stem cells and precancer inflammatory conditions in development of age-specific cancer. Adv Gerontol 21:356–366Google Scholar
  96. Severin FF, Skulachev VP (2009) Programmed cell death as a target to interrupt the aging program. Adv Gerontol 22:37–47PubMedGoogle Scholar
  97. Shnitnikova OA, Kopylova LV, Chernyak EI, Morozov SV, Kolosova NG, Tsentalovich YP (2009) Tryptophan and kynureninelevels in lenses of Wistar and accelerated-senescence OXYS rats. Mol Vis 15:2780–2788Google Scholar
  98. Shram SI, Shilovskii GA, Khokhlov AN (2006) Poly(ADP-ribose)-polymerase-1 and aging: experimental study of possible relationship on stationary cell culture. Bull Exp Biol Med 141:628–632PubMedCrossRefGoogle Scholar
  99. Skulachev VP (2009) New data on biochemical mechanism of programmed senescence of organisms and antioxidant defense of mitochondria. Biochemistry (Moscow) 74:1400–1403CrossRefGoogle Scholar
  100. Skulachev VP, Anisimov VN, Antonenko YN, Bakeeva LE, Chernyak BV, Erichev VP, Filenko OF, Kalinina NI, Kapelko VI, Kolosova NG, Kopnin BP, Korshunova GA, Lichinitser MR, Obukhova LA, Pasuykova EG, Pisarenko OI, Roginsky VA, Ruuge EK, Senin II, Severina II, Skulachev MV, Spivak IM, Tashlimsky VN, Tkachuk VA, Vyssokikh MYu, Yaguzhinsky LS, Zorov DB (2009) An attempt to prevent senescence: a mithochondrial approach. Biochim Biphys Acta 1787:437–461CrossRefGoogle Scholar
  101. Smirnova NV, Spivak IM, Pleskach NM, Zherebtsov SV, Aksenov NL, Mikhelson VM (2008) An atypical case of Werner syndrome: epiogenetic control and DNA damage response allterations. Tsitologiia 50:868–876PubMedGoogle Scholar
  102. Stevens RG (2009) Light-at-night, circadian disruption and breast cancer: assessment of existing evidence. Int J Epidemiol 38:963–970PubMedCrossRefGoogle Scholar
  103. Straif K, Baan R, Grosse Y et al (2007) Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol. 8:1065–1066PubMedCrossRefGoogle Scholar
  104. Tatarinova OV, Nikitin YP (2008) Some demographic indices of the aging and longevity in Yakutia. Adv Gerontol 21:526–534Google Scholar
  105. Tatarinova OV, Kylbanova ES, Neustroeva VN, Semenova AN, Nikitin YP (2008) Phenomenon of supercentenarian in Yakutia. Adv Gerontol 21:198–203PubMedGoogle Scholar
  106. Vinogradova IA, Anisimov VN, Bukalev AV, Semenchenko AV, Zabezhinski MA (2009) Circadian disruption induced by light-at-night accelerates aging and promotes tumorigenesis in rats. Aging 1:855–865PubMedGoogle Scholar
  107. Yashin AI, Romanioukha AA, Mikhalski AI, Novoseltsev VN, Ukraintseva SV, Khalyavkin AV, Anisimov VN (2007) Gerontology in silico: the emergence of a new discipline. Adv Gerontol 20:7–19Google Scholar

Copyright information

© Springer Science+Business Media B.V. 2010

Authors and Affiliations

  • Vladimir N. Anisimov
    • 1
    • 2
  • Vladimir Kh. Khavinson
    • 1
    • 3
  • Olga N. Mikhailova
    • 1
    • 3
  1. 1.Gerontological Society of the Russian Academy of SciencesSt. PetersburgRussia
  2. 2.Department of Carcinogenesis and OncogerontologyN.N. Petrov Research Institute of OncologySt. PetersburgRussia
  3. 3.St. Petersburg Institute of Bioregulation and GerontologySt. PetersburgRussia

Personalised recommendations